NFG
GILD icon

Norris Financial Group’s Gilead Sciences GILD Stock Holding History

Norris Financial Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-16,583
Closed -$2.31M – 85
2026
Q1 		$2.31M Buy
16,583
+213
+1% +$29.8K 0.75% 45
2025
Q4 		$2.01M Buy
16,370
+2,135
+15% +$259K 0.68% 45
2025
Q3 		$1.58M Buy
14,235
+678
+5% +$77.1K 0.58% 50
2025
Q2 		$1.5M Sell
13,557
-2,657
-16% -$283K 0.62% 45
2025
Q1 		$1.82M Sell
16,214
-788
-5% -$81.3K 0.85% 33
2024
Q4 		$1.57M Buy
17,002
+5,366
+46% +$483K 0.74% 36
2024
Q3 		$976K Buy
+11,636
New +$888K 0.48% 47
2020
Q2 		– Sell
-23,379
Closed -$1.75M – 72
2020
Q1 		$1.75M Buy
+23,379
New +$1.62M 1.94% 14

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norris Financial Group's GILD Position: Q2 2026 in Review

Norris Financial Group sold out of Gilead Sciences (GILD) in Q2 2026, closing a stake of 16,583 shares — an estimated $2.31M sold.

Norris Financial Group first reported a position in GILD in Q1 2020 and held it in 8 quarters. The position peaked at $2.31M in Q1 2026. 2,274 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Norris Financial Group reported no remaining Gilead Sciences position as of Q2 2026 after selling out during the quarter.
  • Norris Financial Group sold 16,583 Gilead Sciences shares in Q2 2026, an estimated $2.31M.
  • Norris Financial Group first reported a position in Gilead Sciences in Q1 2020 and held it in 8 quarters.
  • Norris Financial Group's Gilead Sciences position peaked at $2.31M in Q1 2026.
  • 2,274 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Norris Financial Group's 13F filing for Q2 2026, filed 5 Aug 2026.